Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

Novo Nordisk NOVO.B-1.06%decrease; red down pointing triangle filed for U.S. approval of a higher dose of its Wegovy weight-loss injection, with a decision expected within a month or two. The Danish ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription drugs, including popular weight-loss medications Ozempic and Wegovy, asthma ...

Novo Nordisk is using its ticket for an extra-speedy regulatory review granted through the FDA’s Commissioner’s National Priority Voucher (CNPV) program on a higher-dose version of its obesity med ...

Trump and Novo struck a deal earlier this month that Medicare would pay $245 per month for Ozempic and Wegovy under the administration’s attempt to lower US drug costs by tying them to international ...

The new prices will take effect in 2027, and the negotiated prices include a monthly cost of $274 for Novo Nordisk’s (NYSE: NVO) popular GLP-1 drug, semaglutide, sold as Wegovy, Ozempic, and Rybelsus.

Birmingham, Alabama, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Curaechoice, the nation’s #1 leader in No-Cost Benefits Optimization Solutions, announced today that it has selected CVS Caremark at its pharmacy ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases. By Gina Kolata Gina Kolata has ...

Millions of Americans have shed pounds with help from drugs like Wegovy and Zepbound. But people who take these drugs often experience unpleasant side effects. "They lose weight, which is a positive ...

Through the end of March, patients with prescriptions can buy the lowest doses of Ozempic and Wegovy for $199 per month for 2 months and $349 per month after that. HealthDay News — People paying out ...

Over half of people who started using semaglutide (Wegovy) for weight loss ditched it within the first 12 months, a Danish population-based study found. Among 77,310 adults without diabetes who began ...